Data sharing policies for life science research working

The rising popularity of data sharing policies for life science researchers are having an impact, according to a study published in PLOS One.

Researchers from Drexel University, Brandeis University and Massachusetts General Hospital analyzed a 2013 survey of more than 1,600 life science researchers to determine the effects of sharing policies of funding agencies and journals.

“We find that recently enacted data sharing policies and new sharing infrastructure and tools have had a sizable effect on encouraging data sharing,” wrote the authors.

Researchers reported that third-party repositories and online supplements, as well as data sharing requirements of agencies particularly the National Institutes of Health and the National Human Genome Research Institute, were having a large effect on facilitating data sharing.

Despite this progress, still one-third of grant reviewers placed no weight on data sharing in their reviews.

“These patterns suggest that although most of these new policies have been effective, there is still room for policy improvement,” according to the study.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.